About 10 results found for searched term "Methionine Adenosyltransferase" (0.133 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M9788 | PF-9366 | Methionine Adenosyltransferase |
| PF9366 | ||
| PF-9366 is a novel inhibitor of human methionine adenosyltransferase 2A (Mat2A), with IC50 of 420 nM and Kd of 170 nM. | ||
| M10056 | FIDAS-5 | Methionine Adenosyltransferase |
| FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM. | ||
| M14408 | S-Adenosyl-L-methionine tosylate | Metabolite/Endogenous Metabolite |
| S-Adenosyl methionine tosylate; Ademetionine tosylate; AdoMet tosylate | ||
| S-Adenosyl-L-methionine tosylate (S-Adenosyl methionine tosylate) is produced endogenously from methionine and ATP by action of the enzyme methionine adenosyltransferase and is an important orally active methyl group donor. | ||
| M14649 | AGI-24512 | Others |
| AGI-24512 is a methionine adenosyltransferase 2A (MATA2) inhibitor with an IC50 value of 8 nM. | ||
| M28179 | MAT2A inhibitor 2 | Methionine Adenosyltransferase |
| MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor. | ||
| M29574 | AGI-43192 | Somatostatin Receptor |
| AGI-43192 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-43192 is a potent, but limited brain-penetrant compound. AGI-43192 has the potential for exploring the effects of SAM modulation in the central nervous system (CNS) and research of cancer disease. | ||
| M29575 | AGI-41998 | Somatostatin Receptor |
| AGI-41998 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-41998 is a brain-penetrant compound. AGI-41998 has the potential for exploring the effects of SAM modulation in the central nervous system (CNS) and research of cancer disease. | ||
| M29642 | MAT2A inhibitor 3 | Methionine Adenosyltransferase |
| MAT2A inhibitor 3 is a methionine adenosyltransferase 2A (MAT2A) inhibitor, with an IC50 of <200 nM. MAT2A inhibitor 3 can be used for the research of cancers. | ||
| M55363 | IDE397 | Methionine Adenosyltransferase |
| GSK-4362676; MAT2A-IN-9 | ||
| IDE397 (GSK-4362676) is a potent, potential "first-in-class" inhibitor of methionine adenosyltransferase 2A (MAT2A). IDE397 (GSK-4362676) exhibits anti-tumor activity in MTAP-deleted PDX models. | ||
| M56069 | AGI-25696 | Others |
| AGI-25696 is a methionine adenosyltransferase 2A (MATA2 ) inhibitors useful for treatment of cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
